Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Observational study of influenza incidence after Fluarix vaccination in adults aged 50 years and older
2006-002897-23Phase 4Completed
- Sponsor
- GSK
- Start
- Jul 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of Fluarix in influenza (2 arms), sponsored by GSK. Primary endpoints: Incidence of influenza during the influenza season and surveillance period and Incidence of influenza-related complications during the influenza season and surveillance period. Started Jul 2006; status: completed.
02
Drugs
Fluarix
03
Conditions
influenza
Beyond the preview
Go deeper on 2006-002897-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002897-23.